Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

Launch of the Africa office of the IIDE
2006-05-25

Attending the launch of the Africa office of the IIDE were from the left Prof Sytse Strijbos (Chairperson of IIDE Europe), Rev Kiepie Jaftha (Chairperson of the IIDE in Africa’s Board of Directors and Chief Director: Community Service at the UFS) and Prof Frederick Fourie (Rector and Vice-Chancellor of the UFS).

 

Attending the launch were from the left Prof Lucius Botes (Director: Centre of Development Support at the UFS), Dr Samuel Kareithi (Head: Community Development at the Cornerstone Christian College, Cape Town), Rev Kiepie Jaftha (Chairperson of the IIDE in Africa’s Board of Directors and Chief Director: Community Service at the UFS), Prof Sytse Strijbos (Chairperson of IIDE Europe) and Dr Ezekiel Moraka (Vice-Rector:  Student Affairs at the UFS).

Africa office of IIDE launched on UFS main campus 

The Africa office of the International Institute for Development and Ethics (IIDE) was today (26 May 2006) launched on the Main Campus of the University of the Free State (UFS) in Bloemfontein.

“The IIDE specialises in the studying and research of general questions of developmental theory and practices and provides services and support in education, strategic planning, policy formulation, advocacy and capacity building of development agencies,” said Rev Kiepie Jaftha, Chairperson of the IIDE in Africa’s Board of Directors and Chief Director: Community Service at the UFS.

According to Rev Jaftha the IIDE in Africa will focus on the conceptual and normative aspects of developmental processes in Sub-Saharan Africa.  “We want to foster local and international partnerships with various relevant role-players in civil society, the private sector and public sector in the SACD region and later expand our operations to the rest of Africa,” said Rev Jaftha.

The IIDE in Africa cooperates with a similar foundation in Europe, functioning as the IIDE Europe.  This institute was founded in 2003 and its head office is situated in the Netherlands.  The UFS is a funder of the IIDE in Africa together with the Paul Foundation and private sponsors from the Netherlands.

“We have already started with various projects which are in various stages of implementation,” said Rev Jaftha.  Some of these projects include, among others, the broadening of the master’s degree in Christian Studies of Science and Society (MACSSS) which is currently housed at the Vrije Universiteit in Amsterdam to tertiary institutions in South Africa such as the UFS, the University of Stellenbosch and the Potchefstroom Campus of the Northwest University.

“Another project is an investigation into the possibility of initiating a broad development initiative in the poverty stricken Qwaqwa area.  This initiative will attempt to concentrate on issues like the training and empowerment of prospective entrepreneurs in the region, the identification of prospective entrepreneurs for the rendering of development support and the monitoring of the impact of information and communication technology on local communities during the implementation of sustainable development initiatives,” said Rev Jaftha.

“The establishment of the Africa office of the IIDE on the UFS Main Campus is an indication of one of the aims of the UFS to play a role in South Africa and Africa.  It also signifies our aim to contribute meaningfully to research and development and to establish links between the academe and practice,” said Rev Jaftha. 

 

Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
26 May 2006

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept